Fundacao para o Desenvolvimento Medico Hospitalar (UNESP Botucatu)
Botucatu, Brazil
Non-profit organization in Botucatu, State of São Paulo
Rua João Butgnoli, s/n - Distrito de Rubião Jr - Cx 504, Botucatu - SP, 18618-220
About Fundacao para o Desenvolvimento Medico Hospitalar (UNESP Botucatu)
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Actelion
2
Janssen Research & Development, LLC
2
Clinical Trials at Fundacao para o Desenvolvimento Medico Hospitalar (UNESP Botucatu)
During the past decade, Fundacao para o Desenvolvimento Medico Hospitalar (UNESP Botucatu) conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Clinical Study to Compare the Efficacy and Safety of Macitentan and Tadalafil Monotherapies With the Corresponding Fixed-dose Combination Therapy in Subjects With Pulmonary Arterial Hypertension (PAH)
2019-07-29
2024-09-24
Active, not recruiting
187
Efficacy and Safety of M281 in Adults With Warm Autoimmune Hemolytic Anemia
2019-10-24
2027-12-14
Recruiting
111
Outcome Study Assessing a 75 Milligrams (mg) Dose of Macitentan in Patients With Pulmonary Arterial Hypertension
2020-06-30
2026-09-21
Recruiting
900
A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Crohn's Disease
2022-07-22
2030-10-08
Recruiting
715
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Fundacao para o Desenvolvimento Medico Hospitalar (UNESP Botucatu)
According to Clinical.Site data, the most researched conditions in "Fundacao para o Desenvolvimento Medico Hospitalar (UNESP Botucatu)" are
"Crohn's Disease" (1 trials), "Pulmonary Arterial Hypertension" (1 trials), "Pulmonary Arterial Hypertension (PAH) (WHO Group 1 PH)" (1 trials) and "Warm Autoimmune Hemolytic Anemia" (1 trials). Many other conditions were trialed in "Fundacao para o Desenvolvimento Medico Hospitalar (UNESP Botucatu)" in a lesser frequency.
Clinical Trials Intervention Types at Fundacao para o Desenvolvimento Medico Hospitalar (UNESP Botucatu)
Most popular intervention types in "Fundacao para o Desenvolvimento Medico Hospitalar (UNESP Botucatu)" are "Drug" (4 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (3 trials), "Macitentan 10 mg" (2 trials), "FDC macitentan/tadalafil" (1 trials), "Golimumab" (1 trials) and "Guselkumab" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Fundacao para o Desenvolvimento Medico Hospitalar (UNESP Botucatu)
The vast majority of trials in "Fundacao para o Desenvolvimento Medico Hospitalar (UNESP Botucatu)" are
4 trials for "All" genders.
Clinical Trials Status at Fundacao para o Desenvolvimento Medico Hospitalar (UNESP Botucatu)
Currently, there are NaN active trials in "Fundacao para o Desenvolvimento Medico Hospitalar (UNESP Botucatu)".
undefined are not yet recruiting,
3 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in Fundacao para o Desenvolvimento Medico Hospitalar (UNESP Botucatu),
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Fundacao para o Desenvolvimento Medico Hospitalar (UNESP Botucatu), 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".